Related Experiment Videos
Sarcoidosis in children
1Tulane Department of Dermatology, Tulane Medical School, Department of Dermatology, New Orleans, LA 70112.
Insights
Childhood sarcoidosis is rare but presents differently in young children versus older children. Early diagnosis of this multisystem disease is crucial to prevent serious complications like blindness.
Area of Science:
- Pediatrics
- Rheumatology
- Pulmonology
Background:
- Sarcoidosis is a multisystem inflammatory disease of unknown cause.
- It is rarely diagnosed in children, but incidence approaches adult levels with mass screening.
- Childhood sarcoidosis exhibits distinct clinical presentations based on age groups.
Purpose of the Study:
- To summarize the epidemiology and clinical features of childhood sarcoidosis.
- To highlight the differences in presentation between young children and older children.
- To emphasize the importance of early recognition and potential complications.
Main Methods:
- Review of existing literature on childhood sarcoidosis.
- Analysis of epidemiological data and clinical case series.
- Comparison of disease manifestations across different pediatric age groups.
Main Results:
- Two distinct age-related clinical patterns observed: under 4 years (rash, arthritis, uveitis) and 9-15 years (lungs, lymph nodes, eyes, constitutional symptoms).
- Pulmonary and constitutional symptoms are common in older children.
- Mortality is approximately 5%, with 10-20% experiencing long-term sequelae.
Conclusions:
- Childhood sarcoidosis requires age-specific diagnostic considerations.
- Prompt identification can mitigate severe outcomes like blindness and organ damage.
- Further research into etiology and management is warranted.
Abstract:
Sarcoidosis is a multisystem disease of unknown etiology that is rarely diagnosed in children. When mass screening is performed, the incidence of the disease in children approaches that of adults with similar demographics. Most childhood cases occur around ages 9 to 15 years, with small clusters of cases occurring in children under age 4 years. The disease in these two age groups has very different clinical features. Children under age 4 have a clinical triad of rash, arthritis, and uveitis. The classic syndrome in older children involves primarily lungs, lymph nodes, and eyes. In older children, constitutional symptoms (fatigue, lethargy, malaise) and pulmonary symptoms (cough, dyspnea) predominate. Mortality in childhood sarcoidosis is about 5%, with long-term sequelae in 10% to 20%. Early recognition may prevent complications such as blindness, pulmonary insufficiency, and renal impairment.